Standard

Electrospun Carbothane-Based Drug-Enriched Scaffolds for Cardiovascular Devices : Drug Release, Hemocompatibility, Endothelialization, and Immunological Characterization. / Nazarkina, Zhanna K.; Chelobanov, Boris P.; Stepanova, Alena O. и др.

в: International Journal of Molecular Sciences, Том 27, № 11, 5081, 07.06.2026.

Результаты исследований: Научные публикации в периодических изданиях › статья › Рецензирование

Harvard

APA

Vancouver

Nazarkina ZK, Chelobanov BP, Stepanova AO, Imenov A, Laktionov PP. Electrospun Carbothane-Based Drug-Enriched Scaffolds for Cardiovascular Devices: Drug Release, Hemocompatibility, Endothelialization, and Immunological Characterization. International Journal of Molecular Sciences. 2026 июнь 7;27(11):5081. doi: 10.3390/ijms27115081

Author

Nazarkina, Zhanna K. ; Chelobanov, Boris P. ; Stepanova, Alena O. и др. / Electrospun Carbothane-Based Drug-Enriched Scaffolds for Cardiovascular Devices : Drug Release, Hemocompatibility, Endothelialization, and Immunological Characterization. в: International Journal of Molecular Sciences. 2026 ; Том 27, № 11.

BibTeX

@article{e1d966efd40b4943b400c5ca58e27f9e,
title = "Electrospun Carbothane-Based Drug-Enriched Scaffolds for Cardiovascular Devices: Drug Release, Hemocompatibility, Endothelialization, and Immunological Characterization",
abstract = "Polyurethane (PU) is widely used in medical products due to its biocompatibility and mechanical properties. Electrospinning (ES) was employed to produce PU-based scaffolds intended for cardiovascular devices (CVD) from blends of Carbothane (Carb) with human serum albumin (HSA), dimethylacetamide (DMA), and drugs. Sirolimus (SRL)—an immunosuppressive/anti-proliferative drug—and diclofenac (DF)—a nonsteroidal anti-inflammatory drug—were introduced into ES blends to produce drug-enriched scaffolds that prevent inflammation and cell overgrowth. The biocompatibility, stability, and mechanical properties of the scaffolds and SRL release were studied. The scaffolds possessed good mechanical properties and were stable in PBS and blood plasma (BP) for 120 days. The minimal SRL release rate was observed for the scaffold 3%Carb/10%HSA/DMA/SRL. A study of scaffold interaction with blood demonstrated good hemocompatibility of most scaffolds. A study of human gingival fibroblasts, endothelial cells (HUVEC and EA.hy926), and vascular smooth muscle cell interaction with scaffolds in vitro demonstrated variability in cell viability and pro-inflammatory interleukin IL-6 secretion, depending on both the scaffold composition and the cell type. The incorporation of DF into scaffolds decreased the concentration of IL-6 in the culture medium. The scaffold 3%Carb/10%HSA/DMA/SRL is the best choice for CVD in terms of hemocompatibility, endothelialization, and the induction of minimal inflammation.",
keywords = "Carbothane, biocompatibility, drug release, drug-eluting stents, electrospinning, endothelialization, hemocompatibility, polyurethane, sirolimus, vascular graft, сиролимус, электроформование, высвобождение лекарственного препарата, сосудистый протез, стенты с лекарственным покрытием, полиуретан, Carbothane, эндотелиализация, биосовместимость, гемосовместимость",
author = "Nazarkina, {Zhanna K.} and Chelobanov, {Boris P.} and Stepanova, {Alena O.} and Aznaur Imenov and Laktionov, {Pavel P.}",
note = "Nazarkina, Z.K.; Chelobanov, B.P.; Stepanova, A.O.; Imenov, A.; Laktionov, P.P. Electrospun Carbothane-Based Drug-Enriched Scaffolds for Cardiovascular Devices: Drug Release, Hemocompatibility, Endothelialization, and Immunological Characterization. Int. J. Mol. Sci. 2026, 27, 5081. https://doi.org/10.3390/ijms27115081 This study was funded by the Russian Science Foundation grant number 25-25-00617",
year = "2026",
month = jun,
day = "7",
doi = "10.3390/ijms27115081",
language = "English",
volume = "27",
journal = "International Journal of Molecular Sciences",
issn = "1661-6596",
publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",
number = "11",

}

RIS

TY - JOUR

T1 - Electrospun Carbothane-Based Drug-Enriched Scaffolds for Cardiovascular Devices

T2 - Drug Release, Hemocompatibility, Endothelialization, and Immunological Characterization

AU - Nazarkina, Zhanna K.

AU - Chelobanov, Boris P.

AU - Stepanova, Alena O.

AU - Imenov, Aznaur

AU - Laktionov, Pavel P.

N1 - Nazarkina, Z.K.; Chelobanov, B.P.; Stepanova, A.O.; Imenov, A.; Laktionov, P.P. Electrospun Carbothane-Based Drug-Enriched Scaffolds for Cardiovascular Devices: Drug Release, Hemocompatibility, Endothelialization, and Immunological Characterization. Int. J. Mol. Sci. 2026, 27, 5081. https://doi.org/10.3390/ijms27115081 This study was funded by the Russian Science Foundation grant number 25-25-00617

PY - 2026/6/7

Y1 - 2026/6/7

N2 - Polyurethane (PU) is widely used in medical products due to its biocompatibility and mechanical properties. Electrospinning (ES) was employed to produce PU-based scaffolds intended for cardiovascular devices (CVD) from blends of Carbothane (Carb) with human serum albumin (HSA), dimethylacetamide (DMA), and drugs. Sirolimus (SRL)—an immunosuppressive/anti-proliferative drug—and diclofenac (DF)—a nonsteroidal anti-inflammatory drug—were introduced into ES blends to produce drug-enriched scaffolds that prevent inflammation and cell overgrowth. The biocompatibility, stability, and mechanical properties of the scaffolds and SRL release were studied. The scaffolds possessed good mechanical properties and were stable in PBS and blood plasma (BP) for 120 days. The minimal SRL release rate was observed for the scaffold 3%Carb/10%HSA/DMA/SRL. A study of scaffold interaction with blood demonstrated good hemocompatibility of most scaffolds. A study of human gingival fibroblasts, endothelial cells (HUVEC and EA.hy926), and vascular smooth muscle cell interaction with scaffolds in vitro demonstrated variability in cell viability and pro-inflammatory interleukin IL-6 secretion, depending on both the scaffold composition and the cell type. The incorporation of DF into scaffolds decreased the concentration of IL-6 in the culture medium. The scaffold 3%Carb/10%HSA/DMA/SRL is the best choice for CVD in terms of hemocompatibility, endothelialization, and the induction of minimal inflammation.

AB - Polyurethane (PU) is widely used in medical products due to its biocompatibility and mechanical properties. Electrospinning (ES) was employed to produce PU-based scaffolds intended for cardiovascular devices (CVD) from blends of Carbothane (Carb) with human serum albumin (HSA), dimethylacetamide (DMA), and drugs. Sirolimus (SRL)—an immunosuppressive/anti-proliferative drug—and diclofenac (DF)—a nonsteroidal anti-inflammatory drug—were introduced into ES blends to produce drug-enriched scaffolds that prevent inflammation and cell overgrowth. The biocompatibility, stability, and mechanical properties of the scaffolds and SRL release were studied. The scaffolds possessed good mechanical properties and were stable in PBS and blood plasma (BP) for 120 days. The minimal SRL release rate was observed for the scaffold 3%Carb/10%HSA/DMA/SRL. A study of scaffold interaction with blood demonstrated good hemocompatibility of most scaffolds. A study of human gingival fibroblasts, endothelial cells (HUVEC and EA.hy926), and vascular smooth muscle cell interaction with scaffolds in vitro demonstrated variability in cell viability and pro-inflammatory interleukin IL-6 secretion, depending on both the scaffold composition and the cell type. The incorporation of DF into scaffolds decreased the concentration of IL-6 in the culture medium. The scaffold 3%Carb/10%HSA/DMA/SRL is the best choice for CVD in terms of hemocompatibility, endothelialization, and the induction of minimal inflammation.

KW - Carbothane

KW - biocompatibility

KW - drug release

KW - drug-eluting stents

KW - electrospinning

KW - endothelialization

KW - hemocompatibility

KW - polyurethane

KW - sirolimus

KW - vascular graft

KW - сиролимус

KW - электроформование

KW - высвобождение лекарственного препарата

KW - сосудистый протез

KW - стенты с лекарственным покрытием

KW - полиуретан

KW - Carbothane

KW - эндотелиализация

KW - биосовместимость

KW - гемосовместимость

UR - https://www.mendeley.com/catalogue/d9ac793b-f500-39ca-97bb-6e0856085bac/

UR - https://www.scopus.com/pages/publications/105041558240

U2 - 10.3390/ijms27115081

DO - 10.3390/ijms27115081

M3 - Article

C2 - 42278604

VL - 27

JO - International Journal of Molecular Sciences

JF - International Journal of Molecular Sciences

SN - 1661-6596

IS - 11

M1 - 5081

ER -

ID: 85413005